Study Type
Study Type
Study Objective(Purpose of Study)
Study Objective(Purpose of Study)
Study Results
Study Results
Study Quality
Study Quality
1. Amor F, Alcazar JL, Vaccaro H, Leon M, Iturra A. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol. 38(4):450-5, 2011 Oct. Observational-Dx 432 adnexal masses in 372 women Prospective multicenter study to assess the clinical usefulness of a structured reporting system based on US findings for management of adnexal masses. Of the 432 tumors, 112 were malignant and 320 benign. The Gynecologic Imaging Reporting and Data System (GI-RADS) classification rate was as follows: GI-RADS 2, 92 (21%) cases; GI-RADS 3, 184 (43%) cases; GI-RADS 4, 40 (9%) cases; GI-RADS 5, (27%) 116 cases. Sensitivity for this system was 99.1% (95% CI, 95.1-99.8%), specificity was 85.9% (95% CI, 81.7-89.3%), LR+ was 7.05 (95% CI, 5.37-9.45) and LR- was 0.01 (95% CI, 0.001-0.07). PPV and NPV were 71.1% and 99.6%, respectively. The GI-RADS reporting system performed well in identifying adnexal masses at high risk of malignancy and seems to be useful for clinical decision-making. 3
2. Valentin L, Ameye L, Savelli L, et al. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol. 38(4):456-65, 2011 Oct. Observational-Dx 3,511 patients To develop a logistic regression model that can discriminate between benign and malignant adnexal masses perceived to be difficult to classify by subjective evaluation of gray-scale and Doppler US findings (subjective assessment) and to compare its diagnostic performance with that of subjective assessment, serum CA 125 and the risk of malignancy index. One variable was retained in the logistic regression model: the largest diameter (in mm) of the largest solid component of the tumor (odds ratio = 1.04; 95% CI, 1.02-1.06). The model had an AUC of 0.68 (95% CI, 0.59-0.78) on the training set and an AUC of 0.65 (95% CI, 0.53-0.78) on the test set. On the test set, a cut-off of 25% probability of malignancy (corresponding to the largest diameter of the largest solid component of 23 mm) resulted in a sensitivity of 64% (18/28), a specificity of 55% (31/56), an LR+ of 1.44 and an LR- of 0.65. The corresponding values for subjective assessment were 68% (19/28), 59% (33/56), 1.65 and 0.55. On the test set of patients with available CA 125 results, the LR+ and LR- of the logistic regression model (cut-off = 25% probability of malignancy) were 1.29 and 0.73, of subjective assessment were 1.45 and 0.63, of CA 125 (cut-off = 35 U/mL) were 1.24 and 0.84 and of risk of malignancy index (cut-off = 200) were 1.21 and 0.92. About 7% of adnexal masses that are considered appropriate for surgical removal cannot be classified as benign or malignant by experienced US examiners using subjective assessment. Logistic regression models to estimate the risk of malignancy, CA 125 measurements and the risk of malignancy index are not helpful in these masses. 3
3. Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR, Jr. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol. 2003;102(3):594-599. Review/Other-Dx 15,106 asymptomatic women To determine the natural history and estimate the risk of malignancy of unilocular ovarian cystic tumors <10 cm in diameter followed by TVS. The risk of malignancy in unilocular ovarian cystic tumors <10 cm in diameter in women 50 years or older is extremely low. Majority will resolve and can be followed with serial TVS. 4
4. Dorum A, Blom GP, Ekerhovd E, Granberg S. Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: an autopsy study. Am J Obstet Gynecol. 192(1):48-54, 2005 Jan. Review/Other-Dx 234 postmenopausal women Autopsy study was performed to examine the prevalence and histologic condition of adnexal cysts in postmenopausal women. Ovarian cysts were found in 36 of the women (15.4%). Nine women (3.8%) had ovarian cysts with a diameter between 20 and =50 mm; 4 women (1.7%) had cysts that were >50 mm in diameter. Four women had bilateral ovarian cysts. Paraovarian cysts were found in 11 women (4.7%). All cysts were benign, except for 1 woman, who had bilateral serous cystadenoma of borderline type. Macroscopically, the borderline cysts were multilocular with mean diameters of 60 mm and 15 mm, respectively. Because of the high prevalence of benign adnexal cysts, the identification of small unilocular cysts in postmenopausal women should be regarded as a normal finding. 4
5. Levine D, Brown DL, Andreotti RF, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q. 2010;26(3):121-131. Review/Other-Dx N/A Consensus statement on management of ovarian and other adnexal cysts imaged sonographically in asymptomatic women. Recommendations in statement are based on analysis of current literature and common practice strategies. 4
6. Alcazar JL, Castillo G, Jurado M, Garcia GL. Is expectant management of sonographically benign adnexal cysts an option in selected asymptomatic premenopausal women?. Hum Reprod. 20(11):3231-4, 2005 Nov. Review/Other-Dx 120 women Prospective observational longitudinal study to assess whether expectant management of US benign ovarian cysts may be an option for selected asymptomatic premenopausal women. Most lesions remained unchanged both in size and sonographic appearance. In ten patients (8.3%) the lesion disappeared, no patient developed signs or symptoms of ovarian cancer. 4
7. Healy DL, Bell R, Robertson DM, et al. Ovarian status in healthy postmenopausal women. Menopause. 2008;15(6):1109-1114. Review/Other-Dx 515 women To describe the ovaries in healthy women at least 5 years after menopause by questionnaire, TVS, and blood ovarian cancer markers. Both ovaries were identified by TVS in 71% of women. The right ovary was visualized in 86.3% of these volunteers, and the left ovary was visualized in 78%. The presence of small unilocular cysts and echogenic foci facilitated identification of the ovary in some women. Ovarian/paraovarian lesions were present in 12.6% of women. Abnormalities of the endometrium and uterus were also common, prompting surgery in 7.2% of the women. Total serum inhibin concentrations were normal for postmenopausal women, whereas serum CA-125 was elevated in two women. Description and detection of postmenopausal ovaries by TVS allows the identification of both ovaries in most postmenopausal women. US-detected abnormalities of the ovary and/or the uterus/endometrium are common in women at this stage of life. The potential need for surgical intervention after the detection of such abnormalities needs to be carefully evaluated when considering TVS as a screening tool for ovarian cancer. 4
8. Levine D, Gosink BB, Wolf SI, Feldesman MR, Pretorius DH. Simple adnexal cysts: the natural history in postmenopausal women. Radiology. 184(3):653-9, 1992 Sep. Review/Other-Dx 184 asymptomatic postmenopausal volunteers To determine prospectively, the frequency of simple adnexal cysts in postmenopausal women using TAS and TVS associated with hormones and time since menopause. Cyst frequency 17%; 53% disappeared, 28% constant, 11% enlarged, 3% decreased, 6% decreased and increased. No relationship with hormones or time from menopause. 4
9. Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol. 2005;193(4):1323-1330. Observational-Dx 302 consecutive women Review women treated with TVS-guided aspiration for tubo-ovarian abscess to evaluate the usefulness of TVS-guided aspiration and antibiotic therapy for treatment of tubo-ovarian abscess. 282 women (93.4%) were successfully treated. TVS-guided aspiration combined with antibiotics is recommended for treatment of tubo-ovarian abscess. 3
10. Caspi B, Ben-Arie A, Appelman Z, Or Y, Hagay Z. Aspiration of simple pelvic cysts during pregnancy. Gynecol Obstet Invest. 2000;49(2):102-105. Review/Other-Dx 10 patients To determine the value of aspiration of simple pelvic cysts during pregnancy. Aspiration was a definitive treatment for 5/10 women. Aspiration of simple cysts during pregnancy is safe and may prevent surgery. 4
11. Guariglia L, Conte M, Are P, Rosati P. Ultrasound-guided fine needle aspiration of ovarian cysts during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1999;82(1):5-9. Review/Other-Dx 29 patients To evaluate the safety and efficacy of US-guided fine needle aspiration in the treatment of ovarian cysts during pregnancy. In 9 patients, US-guided fine needle aspiration was safely performed as an alternative treatment to surgery. 4
12. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75(6):1023-1028. Review/Other-Tx 10 cases To report on ten cases of malignant neoplasms arising in endometriosis. Tumors arising in endometriosis were predominantly low grade and confined to the site of origin. Radiation therapy was often able to control completely tumors limited to the pelvis, but was not beneficial in metastatic disease. Only one patient had a response to chemotherapy. Fourteen patients received postoperative progestin therapy, with a 77% 5-year survival. Follow-up has been reported in 86 patients. The tumor was either confined to the ovary (57), confined to the extragonadal site of origin (11), or spread throughout the peritoneal cavity (18). With each of these situations, the 5-year survival was 65, 100, and 10%, respectively. Fourteen patients had malignant transformation in endometriosis associated with presumed estrogenic stimulation; most lesions (69%) were well differentiated and the 5-year survival was 82%. 4
13. Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstetrics and gynecology clinics of North America. 2006;33(1):1-11. Review/Other-Dx N/A Review epidemiology of uterine fibroids. No results stated in abstract. 4
14. Comerci JT Jr, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. 84(1):22-8, 1994 Jul. Review/Other-Dx 517 patients To evaluate the clinical and pathologic presentation of mature cystic teratomas and the trends in management over a 14-year study period. 573 tumors were removed from 517 patients. 310 (60%) of the patients were asymptomatic. The mean tumor size was 6.4 +/- 3.5 cm. The bilaterality rate was 10.8%. The rate of torsion was 3.5%; larger tumors underwent torsion more frequently than smaller tumors (P=.029). The rate of malignant transformation was 0.17%. The mean cyst diameter for patients undergoing cystectomy was 5.7 +/- 2.4 cm; for oophorectomy, 8.0 +/- 4.1 cm; and for hysterectomy, 6.1 +/- 3.8 cm. Oophorectomies were performed for larger tumors when compared to cystectomies (P=.01). The number of hysterectomies was stable throughout the study period, whereas the number of oophorectomies decreased and the number of cystectomies increased markedly. Contralateral ovarian biopsy was common (48.5%) early in the study period. By 1989, the biopsy rate was <1%. The prevalence rates of symptomatic tumors, torsion, and malignant degeneration was less than those previously reported by most other investigators. In addition, there has been an important change over the past 14 years in the management of these neoplasms, with an increased tendency for ovarian preservation, as evidenced by the more frequent use of cystectomy and a decrease in contralateral ovarian biopsy. 4
15. Amor F, Vaccaro H, Alcazar JL, Leon M, Craig JM, Martinez J. Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings. J Ultrasound Med. 28(3):285-91, 2009 Mar. Observational-Dx 171 women To describe a new reporting system called the GI-RADS for reporting findings in adnexal masses based on TVS. 187 masses were evaluated. The prevalence rate for malignant tumors was 13.4%. Overall GI-RADS classification rates were as follows: GI-RADS 1, 4 cases (2.1%); GI-RADS 2, 52 cases (27.8%); GI-RADS 3, 90 cases (48.1%); GI-RADS 4, 13 cases (7%); and GI-RADS 5, 28 cases (15%). The sensitivity, specificity, PPV, NPV, and accuracy were 92%, 97%, 85%, 99%, and 96%, respectively. The proposed reporting system showed good diagnostic performance. It is simple and could facilitate communication between sonographers/sonologists and clinicians. 3
16. Kurjak A, Predanic M. New scoring system for prediction of ovarian malignancy based on transvaginal color Doppler sonography. J Ultrasound Med. 11(12):631-8, 1992 Dec. Observational-Dx 812 patients; 174 masses Ovarian lesions assessed by morphological and color Doppler scoring systems to distinguish benign from malignant masses. Color Doppler: sensitivity 97.3%, specificity 100%. Morphological scoring system: sensitivity 92.1%, specificity 94.8%. 3
17. Lucidarme O, Akakpo JP, Granberg S, et al. A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study. Eur Radiol. 20(8):1822-30, 2010 Aug. Observational-Dx 264 women To prospectively assess an innovative computer-aided diagnostic technology that quantifies characteristic features of backscattered US and theoretically allows TVS to discriminate benign from malignant adnexal masses. Among 375 removed ovaries, 141 cancers (83 adenocarcinomas, 24 borderline, 16 cases of carcinomatosis, nine of metastases and nine others) and 234 non-cancerous ovaries (107 normal, 127 benign tumors) were histologically diagnosed. The new computer-aided technology correctly identified 138/141 malignant lesions and 206/234 non-malignant tissues (98% sensitivity, 88% specificity). There were no false-negative results among the 47 FIGO stage I/II ovarian lesions. Standard TVS and CA125 had sensitivities/specificities of 94%/66% and 89%/75%, respectively. Combining standard TVS and the new technology in parallel significantly improved TVS specificity from 66% to 92% (P<0.0001). Computer-aided quantification of backscattered US is a highly sensitive for the diagnosis of malignant ovarian masses. 2
18. Timor-Tritsch LE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol. 168(3 Pt 1):909-13, 1993 Mar. Observational-Dx 93 patients; 115 masses Prospectively analyze scoring system and color flow-directed Doppler measurements to test the hypothesis that a combination of a previously devised morphologic scoring system and color flow-directed Doppler measurements would afford better discrimination between benign and malignant ovarian masses. Score alone: sensitivity 94%, specificity 87%, PPV 60%. With RI or PI: sensitivity 94%, specificity 99%, PPV 94%. Results suggest Doppler flow measurements alone and in conjunction with a scoring system help differentiate benign from malignant masses. 3
19. Alcazar JL, Galan MJ, Garcia-Manero M, Guerriero S. Three-dimensional sonographic morphologic assessment in complex adnexal masses: preliminary experience. J Ultrasound Med. 2003;22(3):249-254. Observational-Dx 41 women (44 masses) To evaluate the role of 3D TVS in assessing complex masses. 41 women with the diagnosis of complex adnexal masses on the basis of 2D TVS were reevaluated by 3D TVS. Sensitivity, specificity, PPV, NPV, and accuracy for 2D and 3D TVS were 90%, 61%, 68%, 87%, and 75% and 100%, 78%, 81%, 100%, and 89%, respectively. 3D TVS does not improve 2D TVS morphologic assessment of complex adnexal masses. 3
20. Coleman BG.. Transvaginal sonography of adnexal masses. [Review] [36 refs]. Radiol Clin North Am. 30(4):677-91, 1992 Jul. Review/Other-Dx N/A Review article on how TVS can contribute to the diagnosis of cystic, complex, and solid adnexal masses. TVS is recommended for evaluation of patients with suspected ectopic pregnancy. It can also be used as the initial procedure in the follow-up of a known adnexal process. 4
21. Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 31(6):681-90, 2008 Jun. Observational-Dx 1,066 patients with 1,233 adnexal tumors To derive simple and clinically useful US-based rules for discriminating between benign and malignant adnexal masses. 903 benign tumors (73%) and 330 malignant tumors (27%) were present. In 167 patients the tumors were bilateral. Five simple rules were chosen to predict malignancy (M-rules): (1) irregular solid tumor; (2) ascites; (3) at least four papillary structures; (4) irregular multilocular-solid tumor with a largest diameter of at least 100 mm; and (5) very high color content on color Doppler examination. Five simple rules were chosen to suggest a benign tumor (B-rules): (1) unilocular cyst; (2) presence of solid components where the largest solid component is <7 mm in largest diameter; (3) acoustic shadows; (4) smooth multilocular tumor less than 100 mm in largest diameter; and (5) no detectable blood flow on Doppler examination. These 10 rules were applicable to 76% of all tumors, where they resulted in a sensitivity of 93%, specificity of 90%, LR+ of 9.45 and LR- of 0.08. When prospectively tested the rules were applicable in 76% (386/507) of the tumors, where they had a sensitivity of 95% (106/112), a specificity of 91% (249/274), LR+ of 10.37, and LR- of 0.06. Most adnexal tumors in an ordinary tumor population can be correctly classified as benign or malignant using simple US-based rules. For tumors that cannot be classified using simple rules, US examination by an expert examiner might be useful. 3
22. Timmerman D, Van Calster B, Testa AC, et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol. 36(2):226-34, 2010 Aug. Observational-Dx 1,938 patients To temporally and externally validate the diagnostic performance of two logistic regression models containing clinical and US variables in order to estimate the risk of malignancy in adnexal masses, and to compare the results with the subjective interpretation of US findings carried out by an experienced US examiner. Of the 1,938 patients included in study, 1,396 had benign, 373 had primary invasive, 111 had borderline malignant and 58 had metastatic tumors. On external validation (997 patients from 12 centers), the AUC for a model containing 12 predictors (LR1) was 0.956, for a reduced model with 6 predictors (LR2) was 0.949 and for subjective assessment was 0.949. Subjective assessment gave a positive LR of 11.0 and a negative LR of 0.14. The corresponding LRs for a previously derived probability threshold (0.1) were 6.84 and 0.09 for LR1, and 6.36 and 0.10 for LR2. On temporal validation (941 patients from seven centers), the AUCs were 0.945 (LR1), 0.918 (LR2) and 0.959 (subjective assessment). Both models provide excellent discrimination between benign and malignant masses. Because the models provide objective and reasonably accurate risk estimation, they may improve the management of women with suspected ovarian pathology. 3
23. Patel MD, Acord DL, Young SW. Likelihood ratio of sonographic findings in discriminating hydrosalpinx from other adnexal masses. AJR. 2006;186(4):1033-1038. Review/Other-Dx 55 patients with 67 cystic adnexal masses To describe the "waist" sign as a feature of hydrosalpinx and to calculate the LR of sonographic findings for predicting that a cystic adnexal mass is a hydrosalpinx. Of the 67 cystic adnexal masses, there were 26 hydrosalpinges (39%), 36 cystic ovarian neoplasms (54%), and five paraovarian masses (7%). The LRs for the sonographic findings were as follows: incomplete septation, 2.1; short linear projection, 3.5; small round projection, 2.7; tubular shape, 10.5; and waist sign, 20.5. The waist sign in combination with tubular shape was found in 12 hydrosalpinges and no other masses (LR of between 18.9 and infinity). Small round projection combined with tubular shape was found in 14 hydrosalpinges and one other mass (LR of 22.1). Hydrosalpinx can be diagnosed with the highest likelihood when a tubular mass with the waist sign or a tubular mass with small round projections is encountered. Incomplete septations and short linear projections are less discriminating findings of hydrosalpinx. 4
24. Timor-Tritsch IE, Rottem S, Elgali S. How transvaginal sonography is done. In: Timor-Tritsch IE, Rottem S, eds. Transvaginal Sonography. London: Heinemann. Medical Books;1988:15-25. Review/Other-Dx N/A Book chapter. N/A 4
25. Alcazar JL, Iturra A, Sedda F, et al. Three-dimensional volume off-line analysis as compared to real-time ultrasound for assessing adnexal masses. Eur J Obstet Gynecol Reprod Biol. 161(1):92-5, 2012 Mar. Observational-Dx 99 women To assess the agreement between three-dimensional volume off-line analysis as compared to real-time ultrasound for assessing adnexal masses. Forty-one masses were malignant and 58 were benign. Agreement between real-time ultrasound and 3D volume analysis was good for both off-line examiners (Kappa index: 0.82, 95% CI: 0.70-0.93 and 0.78, 95% CI: 0.65-0.90). Sensitivities for real-time ultrasound and 3D volume analyses were 100%, 93% and 90%, respectively (p>0.05). Specificities for real-time ultrasound and 3D volume analyses were 91%, 84% and 86%, respectively (p>0.05). 2
26. Alcazar JL, Jurado M. Three-dimensional ultrasound for assessing women with gynecological cancer: a systematic review. [Review]. Gynecol Oncol. 120(3):340-6, 2011 Mar. Review/Other-Dx 46 studies To review critically current evidence of the role of this technique in this clinical setting. Most studies were prospective and observational. Series were small in most of them. Ten studies addressed to technical and reproducibility issues. All of them demonstrate that 3D-US is a reproducible technique among examiners. Studies involving ovarian cancer showed that gray-scale 3D-US is not superior to conventional 2D-US for predicting ovarian cancer. Tumor vascular assessment by 3D power Doppler showed that this method might be useful in a selected subset of adnexal masses. Studies involving endometrial cancer showed that endometrial volume estimation is more specific than endometrial thickness measurement for predicting endometrial cancer. This method is useful for determining myometrial infiltration in women with endometrial cancer. The role of 3D power Doppler in endometrial cancer is controversial. Studies involving cervical cancer showed that tumor vascularity as assessed by 3D power Doppler correlates with prognostic tumor features. 4
27. Vrachnis N, Sifakis S, Samoli E, et al. Three-dimensional ultrasound and three-dimensional power Doppler improve the preoperative evaluation of complex benign ovarian lesions. Clin Exp Obstet Gynecol. 2012;39(4):474-478. Review/Other-Dx 29 patients To evaluate the diagnostic accuracy of three-dimensional ultrasound (3D-US) and three-dimensional power-Doppler (3DPD-US) as adjuncts to conventional B-mode-US in evaluation of complex benign ovarian lesions. Seven out of the 16 cases of endometriomas (44%) were graded as low risk masses according to B-mode-US, while the addition of 3D-US and 3DPD-US increased the accuracy to 56% and 94%, respectively. All dermoid cysts were classified as high risk cases by B-mode-US, but 3D-US and 3DPD-US correctly classified 14% and 57% of cases, respectively. The use of B-mode-US, 3D-US and 3DPD-US correctly classified all four cystadenomas. Only the use of 3DPD-US correctly classified one out of two hemorrhagic corpus luteum cases, whereas the other imaging modalities characterized these lesions as high risk. The overall diagnostic accuracy increased from 38%, 48%, ana 83% with the application of B-mode-US alone, or combined with 3D-US and 3DPD-US, respectively. 4
28. Radosa MP, Vorwergk J, Fitzgerald J, et al. Sonographic discrimination between benign and malignant adnexal masses in premenopause. Ultraschall Med. 2014;35(4):339-344. Observational-Dx 1320 patients To assess the diagnostic value of sonographic pattern recognition by experts, a standardized morphological scoring system, the risk malignancy index (RMI) and CA 125 assay for the preoperative assessment of ovarian lesions in premenopausal patients. Pattern recognition showed the highest discriminative power with an observed kappa of 0.53. Sensitivity and specificity yielded 0.76 and 0.97 respectively. Combining pattern recognition with CA 125 serum measurement in the context of a triage system diminished the diagnostic value (kappa: 0.24; sensitivity: 0.29 specificity: 0.97). For the RMI we observed a sensitivity of 0.54 and a specificity of 0.96 and estimated kappa value yielded 0.37. Omitting the CA 125 assay and using a morphological sonographic assessment system increased the kappa value to 0.45 with sensitivity and specificity observed at 0.61 and 0.97 respectively. 2
29. Brown DL, Doubilet PM, Miller FH, et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology. 208(1):103-10, 1998 Jul. Observational-Dx 194 patients (211 lesions) To determine the gray-scale and Doppler US features that best enable discrimination between malignant and benign ovarian masses and develop a scoring system for accurate diagnosis with these features. 28 malignant, 183 benign masses. Masses with markedly hyperechoic solid component or no solid component were benign. In masses with non-hyperechoic solid component, other features helped to discriminate between benign and malignant masses. Scoring formula developed, cut off score yielded sensitivity of 93% and specificity of 93%. 2
30. Guerriero S, Ajossa S, Risalvato A, et al. Diagnosis of adnexal malignancies by using color Doppler energy imaging as a secondary test in persistent masses. Ultrasound Obstet Gynecol. 11(4):277-82, 1998 Apr. Observational-Dx 192 consecutive lesions Prospective study to compare the accuracy of B-mode TVS alone and in combination with color Doppler energy (or power Doppler) imaging in differentiating benign from malignant adnexal masses. 159 benign, 33 malignant. Intratumoral arterial blood flow detected in 100% malignant and in 94% benign. Combined use of TVS and color Doppler has greater accuracy for diagnosing ovarian malignancy than TVS alone (kappa: 0.81 and 0.63). 3
31. Alcazar JL, Guerriero S, Laparte C, Ajossa S, Jurado M. Contribution of power Doppler blood flow mapping to gray-scale ultrasound for predicting malignancy of adnexal masses in symptomatic and asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 155(1):99-105, 2011 Mar. Observational-Dx 1,094 women To determine the contribution of power Doppler blood flow mapping to gray-scale US for predicting malignancy of adnexal masses in symptomatic and asymptomatic women. Definitive histological diagnosis used as standard reference. In group A, B-mode was significantly more sensitive (98.1%) than Doppler US (91.3%) (P<0.01). In group B Doppler US (97.0%) was more specific than B-mode US (92.2%) (P<0.001). In group C Doppler US (84.0%) was more specific than B-mode US (68.0%) (P<0.001). Positive LR was significantly higher after Doppler evaluation in all groups (30.5 vs 12.8 in group A, 33.2 vs 12.8 in group B and 6.0 vs 3.1 in group C). The diagnostic performance of B-mode and power Doppler US is different depending on patients' complaints. 3
32. Guerriero S, Alcazar JL, Ajossa S, et al. Transvaginal color Doppler imaging in the detection of ovarian cancer in a large study population. Int J Gynecol Cancer. 20(5):781-6, 2010 Jul. Observational-Dx 2,148 pelvic masses To compare the diagnostic accuracy of grayscale US and that of color Doppler imaging in the diagnosis of ovarian malignancy in a prospective study by the Sardinia-Navarra group. 468 masses were malignant. Color Doppler evaluation was more accurate in the diagnosis of adnexal malignancies in comparison with grayscale US because of a significantly higher specificity (94% vs 89%, P=0.001), with similar sensitivity (95% vs 98%, P=0.44). The pretest probability of ovarian cancer was 22%, and this probability rose to 82% when the diagnosis was suggested by color Doppler evaluation. The diagnostic accuracy of the tests was also dependent on menopausal status. The evaluation of vessel distribution by color Doppler US in adnexal masses increases the diagnostic accuracy of grayscale sonography in the detection of adnexal malignancies in a large study population. 3
33. Schelling M, Braun M, Kuhn W, et al. Combined transvaginal B-mode and color Doppler sonography for differential diagnosis of ovarian tumors: results of a multivariate logistic regression analysis. Gynecol Oncol. 77(1):78-86, 2000 Apr. Observational-Dx 257 patients To determine if color-coded Doppler US can improve the diagnostic accuracy of B-mode US in ovarian masses. Preoperative B-mode and Doppler US was performed prospectively in 63 patients with unclear adnexal lesions prior to operation. Using multiple logistic regression, the independent variables of each procedure were selected and combined to yield a diagnostic flow chart. 39 malignant, 218 benign. Combining independent significant variables of 2 procedures raised the diagnostic accuracy to 90% (sensitivity 86%, specificity 93%). The validity achieved by this combination was confirmed by the independent application of this method to the 257 adnexal tumors with unclear malignancy status (diagnostic accuracy 93%, sensitivity 92%, and specificity 94%).Combination of US and Doppler US yields high and reproducible diagnostic accuracy. 3
34. Alcazar JL, Rodriguez D. Three-dimensional power Doppler vascular sonographic sampling for predicting ovarian cancer in cystic-solid and solid vascularized masses. J Ultrasound Med. 28(3):275-81, 2009 Mar. Observational-Dx 143 consecutive women To explore the role of 3D power Doppler US to discriminate between benign and malignant cystic-solid and solid vascularized adnexal masses and to define cutoff values for 3D power Doppler US indices to be used in a clinical setting. 113 masses (74%) were malignant, and 39 (26%) were benign. Morphologic evaluation revealed 30 unilocular solid masses (19.7%), 43 multilocular solid masses (28.3%), and 79 mostly solid masses (52%). The mean vascularization index (9.365% vs 3.3%; P<.001), flow index (34.318 vs 28.794; P<.001), and vascularization-flow index (3.233 vs1.15; P<0.01) were significantly higher in malignant tumors. No differences were found in the RI, PI, and peak systolic velocity. AUC revealed 0.77 (95% CI, 0.69-0.85), 0.71 (0.60-0.81), and 0.75 (0.66-0.83) for the vascularization index, flow index and vascularization-flow index, respectively. For reducing the false-positive rate by almost one-third, sensitivity values for the vascularization index (cutoff, 1.556%), flow index (25.212%), and vascularization-flow index (0.323%) were 92%, 95%, and 93%, respectively. 3D power Doppler US vascular indices could be helpful for reducing the false-positive rate in cystic-solid and solid vascularized adnexal masses. 3
35. Mansour GM, El-Lamie IK, El-Sayed HM, et al. Adnexal mass vascularity assessed by 3-dimensional power Doppler: does it add to the risk of malignancy index in prediction of ovarian malignancy?: four hundred-case study. Int J Gynecol Cancer. 19(5):867-72, 2009 Jul. Observational-Dx 400 cases of ovarian masses To determine whether adnexal mass vascularity assessed by 3D power Doppler adds to the risk of malignancy index in prediction of ovarian malignancy. Sensitivity of risk of malignancy index for prediction of malignancy was 88%, with a cutoff value of 202.5 at 95% CI. Sensitivity of 3D power Doppler for prediction of malignancy was 75%, adding 3D power Doppler to risk of malignancy index increased its sensitivity to 99%. Considering the pilot nature of the study, further studies are needed to corroborate such findings. 3
36. Schneider VL, Schneider A, Reed KL, Hatch KD. Comparison of Doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses. Obstet Gynecol. 81(6):983-8, 1993 Jun. Observational-Dx 55 patients Cross-sectional study to assess the validity of Doppler flow US for the prediction of malignancy in adnexal masses and to compare the results with 2D US examination and CA 125 levels. Doppler US evaluation of RI in the vessels of adnexal masses increased the sensitivity of 2D US and CA 125. However, 46% of positive Doppler results were false and 37.5% of the benign tumors had low RI, thus limiting the validity of this technique for screening programs. 2
37. Chou CY, Chang CH, Yao BL, Kuo HC. Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors. J Clin Ultrasound. 22(8):491-6, 1994 Oct. Observational-Dx 108 patients To evaluate the use of Color Doppler US and CA 125 in adnexal masses before surgery. A combination of color Doppler US and CA 125 is effective in differentiating benign from malignant tumors. A combination of RI and CA 125 gives sensitivity of 100%, NPV 100%. 3
38. Mancuso A, De Vivo A, Triolo O, Irato S. The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses. Eur J Gynaecol Oncol. 25(2):207-10, 2004. Observational-Dx 125 women To evaluate the ability of CA 125 and US alone and in combination with clinical parameters (>50 years and postmenopausal state) in the diagnosis of a malignant pelvic mass. The best results were obtained from the association of CA 125 and menopause; an increase in CA 125 in menopausal women most likely suggests pelvic mass is malignant. 3
39. Hartman CA, Juliato CR, Sarian LO, et al. Ultrasound criteria and CA 125 as predictive variables of ovarian cancer in women with adnexal tumors. Ultrasound Obstet Gynecol. 40(3):360-6, 2012 Sep. Observational-Dx 103 women To evaluate the capacity to predict malignancy in women with adnexal tumors using CA 125 measurement and ultrasound criteria. Of 110 tumors, 79 (71.8%) were benign and 31 (28.2%) were malignant on histopathology. Ultrasound criteria could be applied to 91 (82.7%) tumors, resulting in a sensitivity of 90%, specificity of 87%, positive predictive value (PPV) of 69% and negative predictive value (NPV) of 97%. In tumors not classifiable according to ultrasound criteria, subjective sonographic assessment gave a sensitivity of 67%, specificity of 80%, PPV of 75% and NPV of 73%. At a cut-off point of 37.4 U/mL, CA 125 had a sensitivity of 69%, a specificity of 87.8%, a PPV of 69% and a NPV of 88% for detection of malignancy. When CA 125 was associated with age and ultrasound criteria in a logistic regression model, the sensitivity and specificity increased in the subset of sonographically malignant tumors. 3
40. Goh W, Bohrer J, Zalud I. Management of the adnexal mass in pregnancy. Curr Opin Obstet Gynecol. 2014;26(2):49-53. Review/Other-Dx N/A To highlight the increasing sensitivity of ultrasound imaging in diagnosing the rare malignant lesion, allowing for antenatal expectant management of benign asymptomatic adnexal masses until delivery or postpartum. Most adnexal masses are benign and ultrasound characteristics can help guide the assessment of asymptomatic ovarian masses. When surgical management is chosen, laparoscopy can be safely performed in pregnancy. Ovarian torsion is a complication for persistent masses in pregnancy. 4
41. Zanetta G, Mariani E, Lissoni A, et al. A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy. BJOG. 2003;110(6):578-583. Review/Other-Dx 6636 women To assess the clinical relevance of adnexal masses in pregnancy and the usefulness of ultrasound in their management. We detected 82 cysts in 79 of 6636 women (1.2 in 100 term pregnancies). Sixty-eight women were asymptomatic at the time of diagnosis, whereas 11 (13.9%) were diagnosed because of pain. Diagnosis occurred in the first trimester for 57 cases and in the second or third trimester in 22 (27.8%). One-half of the cysts were simple and anechoic at ultrasound. Fifty-seven had a diameter not exceeding 5 cm. Forty-two cyst resolved in pregnancy without treatment. Three cysts required surgery within few days (torsion). One woman required laparotomy at the 37th week of gestation, due to torsion. When one case of termination was excluded, 78 women delivered at term (66 vaginally, 12 by caesarean section). Nineteen women underwent surgery after pregnancy. We recorded three Stage Ia borderline tumours, accounting for 3/82 cysts (3.6%) and 3/30 persisting masses (10%). 4
42. Zhang X, Mao Y, Zheng R, et al. The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US - a multicenter study. PLoS One. 2014;9(4):e93843. Observational-Dx 120 patients To evaluate the efficacy of qualitative analysis of contrast-enhanced ultrasound (CEUS) in discrimination of adnexal masses which were undetermined by conventional ultrasound (US). There were 48 malignant tumors and 72 benign tumors. The enhancement features of malignant masses were different from benign ones. Earlier or simultaneous enhancement with inhomogeneous enhancement yielded the highest capability in differential diagnosis, and Sen, Spe, PPV, NPV, ACC, Youden's index was 89.6%, 97.2%, 93.2%, 95.6%, 93.3%, and 0.88, respectively. 3
43. Hu R, Xiang H, Mu Y, Feng Y, Gu L, Liu H. Combination of 2- and 3-dimensional contrast-enhanced transvaginal sonography for diagnosis of small adnexal masses. J Ultrasound Med. 33(11):1889-99, 2014 Nov. Observational-Dx 57 cases To evaluate the efficacy of the combination of 2-dimensional (2D) and 3-dimensional (3D) contrast-enhanced sonography in discriminating between benign and malignant small adnexal masses. Forty-seven cases of benign and 10 cases of malignant small adnexal masses were discovered. Significant differences in perfusion patterns, time-intensity curve shapes for 2D contrast-enhanced sonography, grayscale contrast-enhanced sonography, and blood flow imaging on 3D contrast-enhanced sonography were observed between benign and malignant masses (P< .05). Two-dimensional contrast-enhanced sonography, 3D contrast-enhanced sonography, parallel combination of 2D and 3D contrast-enhanced sonography, and serial combination of 2D and 3D contrast-enhanced sonography all reached diagnostic sensitivity of 100% for discriminating benign from malignant masses, whereas specificity values were 61.7%, 63.8%, 68.1%, and 57.4%, respectively. Areas under the receiver operating characteristic curves were 0.809, 0.819, 0.840, and 0.787. 2
44. Xiang H, Huang R, Cheng J, et al. Value of three-dimensional contrast-enhanced ultrasound in the diagnosis of small adnexal masses. Ultrasound Med Biol. 2013;39(5):761-768. Observational-Dx 47 patients To determine whether three-dimensional contrast-enhanced ultrasound (3D-CEUS) can provide useful information to distinguish malignant from benign adnexal masses (#4 cm). The 51 masses included 43 benign and 8 malignant lesions. On 3D-CEUS images, benign lesions appeared as round structures formed by sparse and straight capillary vessels. Malignant lesions showed irregular stereo structures with dense and tortuous vascular distribution. A 3D-CEUS scoring system was established. There were no statistically significant differences in scores at each time point between the 20th and 70th seconds, and the area under the receiver operating characteristic curve for this time period was the largest (0.995). A cut-off score of 8 was established, with scores >/=8 being suggestive of malignancy. The 3D-CEUS scoring system had a high sensitivity (100%) and specificity (98%). 2
45. Huchon C, Metzger U, Bats AS, et al. Value of three-dimensional contrast-enhanced power Doppler ultrasound for characterizing adnexal masses. J Obstet Gynaecol Res. 38(5):832-40, 2012 May. Observational-Dx 99 patients To assess the diagnostic performance of 3-D contrast-enhanced power Doppler ultrasonography (3-D CEPDUS) for differentiating benign and malignant adnexal masses. Of 99 patients, 88 had benign tumors and were compared to the 11 patients with borderline (n = 5) or malignant (n = 6) tumors. The sensitivity of the subjective 2-D score was 55% (95% confidence interval [CI], 25-84) and specificity 94% (95%CI, 89-99). The sensitivity of the subjective 3-D score was 82% (95%CI, 58-100) and specificity 90% (95%CI, 83-96). Improvement of detection of malignant or borderline tumors by subjective 3-D score was 150%. Vessel density and patterns were not more efficient than the subjective 3-D score. The mean vascular index values were significantly different between benign and borderline/malignant groups: VI, 7.2 versus 35.5 (P < 0.0001); FI, 37.0 versus 48.2 (P = 0.003); and VFI, 2.9 versus 17.6 (P < 0.0001), respectively. 1
46. Anthoulakis C, Nikoloudis N. Pelvic MRI as the "gold standard" in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol. 2014;132(3):661-668. Review/Other-Dx 10 references To conduct a systematic review, following the PRISMA guidelines, and critically appraise pelvic MR Imaging as the preferred advanced second imaging test, as regards detection of ovarian cancer and assessment of indeterminate adnexal masses, with respect to pre-operatively improving the assignment of these patients to the appropriate level of care. Computerized database search revealed 37 citations of relevance, 10 of which fulfilled the inclusion/exclusion criteria. From the aforementioned, 8 articles were acquired (2 authors were contacted but did not respond) as well as assessed with AHRQ, QUADAS, and STARD evaluation tools. Finally, 6 papers (5 prospective and 1 retrospective) were included in the systematic review. 4
47. Sohaib SA, Mills TD, Sahdev A, et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol. 60(3):340-8, 2005 Mar. Observational-Dx 72 women Prospective study to evaluate the accuracy of US and MRI in characterizing adnexal masses and to determine which patients may benefit from MRI. Sensitivity (US 100%, MRI 96.6%). Specificity (US 39.5%, MRI 83.7%). Accuracy (US 63.9%, MRI 88.9%). MRI is more specific and accurate than US and Doppler assessment for characterizing adnexal masses. 2
48. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol. 2003;180(5):1297-1304. Observational-Dx 104 patients (163 lesions) Prospective study to evaluate the accuracy of MRI in the detection and characterization of adnexal masses and to determine which imaging features are predictive of malignancy. MR1: 95% lesions were detected. Accuracy 91%. MRI is highly accurate in characterization of adnexal masses and the best predictors of malignancy are vegetation in a cystic lesion and ascites. 2
49. Adusumilli S, Hussain HK, Caoili EM, et al. MRI of sonographically indeterminate adnexal masses. AJR. 2006;187(3):732-740. Observational-Dx 87 patients (95 lesions) Retrospective, blinded review to assess the ability of MRI to characterize sonographically indeterminate adnexal masses and to define the US features contributing to indeterminate diagnoses. Sensitivity of MRI for identifying malignancy (n=5) was 100%, specificity for benignity (n=90) was 94%. Main reason for indeterminate US was inability to determine origin because of location and large mass size and appearance of purely solid or complex cystic masses. 2
50. Haggerty AF, Hagemann AR, Chu C, Siegelman ES, Rubin SC. Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses. Int J Gynecol Cancer. 2014;24(7):1215-1221. Observational-Dx 237 female patients To determine the accuracy of pelvic magnetic resonance imaging (MRI) diagnoses compared with the final pathology diagnoses for a series of women with indeterminate adnexal masses. Data from 237 female patients who underwent pelvic MRI were included, and 41.35% underwent surgical intervention for the adnexal mass. Pelvic MRI (n = 88) was determined to have a sensitivity of 95.0% and specificity of 94.1%. The predicted specific histologic subtype by MRI (n = 84) was accurate in 56 (98.25%) of 57 women with an anticipated benign diagnosis and in 23 (85.19%) of 27 women with an anticipated malignancy. The agreement between a benign diagnosis from MRI and benign final surgical pathology was 0.85 (95% confidence interval, 0.716-0.976). 3
51. Thomassin-Naggara I, Darai E, Cuenod CA, et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol. 2009;19(6):1544-1552. Observational-Dx 77 women with complex adnexal masses (30 benign and 47 malignant) To prospectively assess the contribution of DWI MRI for characterizing complex adnexal masses. The most significant criteria for predicting benignity were low b(1,000) signal intensity within the solid component (PLR = 10.9), low T2 signal intensity within the solid component (PLR = 5.7), absence of solid portion (PLR = 3.1), absence of ascites or peritoneal implants (PLR = 2.3) and absence of papillary projections (PLR = 2.3). ADC measurements did not contribute to differentiating benign from malignant adnexal masses. All masses that displayed simultaneously low signal intensity within the solid component on T2-weighted and on b(1,000) DWIs were benign. Alternatively, the presence of a solid component with intermediate T2 signal and high b(1,000) signal intensity was associated with a PLR of 4.5 for a malignant adnexal tumor. DWI signal intensity is an accurate tool for predicting benignity of complex adnexal masses. 3
52. Cappabianca S, Iaselli F, Reginelli A, et al. Value of diffusion-weighted magnetic resonance imaging in the characterization of complex adnexal masses. Tumori. 2013;99(2):210-217. Observational-Dx 91 patients To define the role of diffusion-weighted imaging in the characterization of adnexal complex masses, with particular regard to the distinction between benign and malignant lesions. With regard to the solid components, hypointensity on both the T2-weighted and diffusion-weighted images has proved to be a reliable indicator of benignancy. In contrast, hyperintensity on both sequences was suggestive of malignancy. Signal intensity of the cystic components and apparent diffusion coefficient values of both components have not proven useful in characterization of the masses. 2
53. Kierans AS, Bennett GL, Mussi TC, et al. Characterization of malignancy of adnexal lesions using ADC entropy: comparison with mean ADC and qualitative DWI assessment. J Magn Reson Imaging. 2013;37(1):164-171. Observational-Dx 37 female adults To establish the utility of apparent diffusion coefficient (ADC) entropy in discrimination of benign and malignant adnexal lesions, using histopathology as the reference standard, via comparison of the diagnostic performance of ADC entropy with mean ADC and with visual assessments of adnexal lesions on conventional and diffusion-weighted sequences. No statistically significant difference was observed in mean ADC between benign and malignant adnexal lesions (P = 0.768). ADC entropy was significantly higher in malignant than in benign lesions (P = 0.009). Accuracy was significantly greater for ADC entropy than for mean ADC (0.018). ADC entropy and visual assessment by the less-experienced reader showed similar accuracy (P >/= 0.204). The more experienced reader's accuracy was significantly greater than that of all other assessments (P </= 0.039). 3
54. Thomassin-Naggara I, Toussaint I, Perrot N, et al. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology. 2011;258(3):793-803. Observational-Dx 87 women To retrospectively determine the value of adding perfusion-weighted and DWI sequences to a conventional MRI protocol to differentiate benign from malignant tumors. Three independent observers reviewed images. There was almost perfect agreement for lesion characterization regardless of the reader experiment or step considered (? = 0.811-0.929). AUC values were higher for conventional and DW images combined, conventional and perfusion-weighted images combined, and conventional, DWI, and perfusion-weighted images combined compared with conventional MRI alone (P<.05). For all readers, the accuracy of conventional, perfusion-weighted, and DWI combined was higher than that of conventional MRI alone for benign masses (P<.01) but not for malignant masses (P=.24). The addition of both perfusion-weighted and DWI led to a correct change in the diagnosis in 19% (11/57 patients), 23% (13/57 patients), and 24% (14/57 patients) of cases for readers 1, 2, and 3, respectively, with no incorrect changes. Conventional, perfusion-weighted, and DWI MRI criteria were combined to generate a decision tree giving an accuracy of 95%. The addition of perfusion-weighted and DWI sequences to a conventional MRI protocol improved the diagnostic accuracy in the characterization of complex adnexal masses. 2
55. Bernardin L, Dilks P, Liyanage S, Miquel ME, Sahdev A, Rockall A. Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation. Eur Radiol. 2012;22(4):880-890. Observational-Dx 63 patients To determine whether threshold criteria using semi-quantitative multiphase-dynamic contrast-enhanced magnetic resonance imaging (DCE- MRI) can improve prediction of malignancy in complex adnexal masses. There was a significant difference in mean SI(max) (P < 0.05), SI(rel) (P < 0.01) and WIR (P < 0.001) between benign and borderline/invasive malignant groups. A cut-off WIR >/= 9.5 l/s had a specificity of 88% and positive predictive value of 86% for predicting malignancy, significantly better than conventional MRI (62%, P < 0.01). WIR <8.2 l/s had a negative predictive value of 94%. 2
56. Tang YZ, Benardin L, Booth TC, et al. Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses. Br J Radiol. 2014;87(1043):20130730. Observational-Dx 71 indeterminate lesions To assess if the use of a lesion-to-internal-reference ratio improved the performance in characterizing adnexal masses and which internal reference was suitable. When the wash in rate of the lesion was higher than that of the myometrium, 97% specificity and 12% sensitivity for borderline/malignancy was reached. When the maximum relative enhancement and maximum absolute enhancement (SImax) of the lesion was less than those of the psoas, 100% specificity for benignity was achieved. The highest area under the curve (AUC) (0.807) was achieved using a SImax lesion-myometrium ratio. A slightly lower AUC (0.799) was achieved using a SImax lesion-psoas ratio, but the psoas muscle was more frequently measurable in the same slice as the lesion ROI. Although the AUC was higher, when using ratios instead of individual DCE values, this was not significantly different. 2
57. Thomassin-Naggara I, Balvay D, Aubert E, et al. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol. 2012;22(4):738-745. Observational-Dx 56 women To evaluate the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to differentiate malignant from benign adnexal tumours. Malignant tumours displayed higher F(T), Vb, rAUC and lower Ve than benign tumours (P < 0.0001, P = 0.0006, P = 0.04 and P = 0.0002, respectively). F(T) was the most relevant factor for discriminating malignant from benign tumours (AUROC = 0.86). Primary ovarian invasive tumours displayed higher F(T) and shorter Dt than borderline tumours. Malignant adnexal tumours with associated peritoneal carcinomatosis at surgery displayed a shorter Dt than those without peritoneal carcinomatosis at surgery (P = 0.01). 3
58. American College of Radiology. Manual on Contrast Media. Available at: Review/Other-Dx N/A Guidance document on contrast media to assist radiologists in recognizing and managing risks associated with the use of contrast media. N/A 4
59. Togashi K.. Ovarian cancer: the clinical role of US, CT, and MRI. [Review] [55 refs]. Eur Radiol. 13 Suppl 4:L87-104, 2003 Dec. Review/Other-Dx N/A Review the clinical roles of US, CT and MRI in the diagnosis of ovarian cancer. US is the modality of choice in evaluation of suspected adnexal masses. CT is not indicated for differential diagnosis of adnexal masses because of poor soft tissue discrimination. MRI may help in distinguishing benign from malignant. 4
60. American College of Radiology. ACR Appropriateness Criteria®: Staging and Follow-up of Ovarian Cancer. Available at: Review/Other-Dx N/A To provide guidelines for staging and follow-up of ovarian cancer. No abstract available. 4
61. Fenchel S, Grab D, Nuessle K, et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology. 223(3):780-8, 2002 Jun. Observational-Dx 99 consecutive patients Prospective study to analyze asymptomatic adnexal masses at PET with FDG in correlation with histopathologic findings and evaluate FDG-PET for assessing malignancy in comparison with TVUS B-mode and Doppler US and MRI. Overall sensitivities and specificities were 58% and 76%, respectively, for FDG-PET; 92% and 60%, respectively, for US; 83% and 84%, respectively, for MRI; and 92% and 85% respectively, for the combination of 3 modalities. US remains the method of choice for diagnosis and assessment of asymptomatic adnexal masses. 2
62. Zor E, Stokkel MP, Ozalp S, Vardareli E, Yalcin OT, Ak I. F18-FDG coincidence-PET in patients with suspected gynecological malignancy. Acta Radiol. 2006;47(6):612-617. Observational-Dx 18 women To assess the role of FDG imaging with a dual-head coincidence mode gamma camera (Co-PET) in identifying malignant tumors in patients with a suspicious adnexal mass depicted by conventional imaging methods. Histopathological examinations of the surgically excised adnexal masses revealed eight malignant, one borderline, and nine benign neoplastic tumors. Four benign tumors had no FDG uptake, while the remaining 5 tumors, all leiomyomas, showed mild FDG accumulation. Eight malignant tumors showed intense FDG uptake. Sensitivity, specificity, PPV, and NPV of FDG co-PET in differentiating benign from malign adnexal masses were 88%, 44%, 61%, and 80%, respectively. Tumor to background ratios in benign lesions (2.04 +/- 0.27) was significantly lower than in malignant lesions (7.4 +/- 0.99). FDG Co-PET is of clinical value when assessing suspicious malignant adnexal masses. False-negative FDG results might arise from borderline disease. Moderate FDG uptake in leiomyomas can result false-positive, but tumor to background ratios may be helpful in such cases. 3